Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
12.7M
-
Shares change
-
-1.09M
-
Total reported value, excl. options
-
$29.2M
-
Value change
-
-$4.28M
-
Number of buys
-
7
-
Number of sells
-
-20
-
Price
-
$2.29
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2018
40 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2018.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.7M shares
of 386M outstanding shares and own 3.3% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (1.64M shares), Paradice Investment Management LLC (1.58M shares), JANUS HENDERSON GROUP PLC (1.39M shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (990K shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (974K shares), 22NW, LP (954K shares), HEARTLAND ADVISORS INC (885K shares), Russell Investments Group, Ltd. (841K shares), Lapides Asset Management, LLC (642K shares), and RENAISSANCE TECHNOLOGIES LLC (596K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.